1Pacific Tuberculosis and Cancer Research Organization, Los Angeles, California, USA. lifu@patcar.org
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Thalidomide shows potential as an adjuvant therapy for tuberculosis by modulating immune responses. It suppresses inflammation and enhances T cell activity, particularly beneficial for severe cases.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: